A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

Clinical trial NCT02946541 · COMPLETED

Trial details

NCT number: NCT02946541
Sponsor: Dong-A ST Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2013-07-01
Primary completion: 2014-10-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.